Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742
Published April 10, 2019 · Recall initiated: March 5, 2018
Summary
FDA records drug Class II recall D-1077-2019, published April 10, 2019 and initiated March 5, 2018. Recalling firm: Johnson Matthey Inc.; Status: Terminated; Reported quantity: 169.976 kg; Lot: Lot# B1414-160809, Retest Date AUG 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Johnson Matthey Inc.
- Distributor
- Nationwide in the US
- Lot
- Lot# B1414-160809, Retest Date AUG 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive,October 2, 2019
- FDARemifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 gApril 24, 2019
- FDALosartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati,April 10, 2019
- FDANORepinephrine 16 mg added to 0.9% Sodium Chloride (PF), 16 mg / 250 mL, 250 mL IV bag, Rx only, KRS GlobalApril 10, 2019
- FDAPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: JubilantApril 10, 2019
- FDAPremium Sustainable Atlantic Salmon (Farm Raised); 22 lb. case - Master carton - corrugated cardboard box.April 10, 2019
Questions about this recall
Was Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742 recalled?
Yes. FDA published recall D-1077-2019 on April 10, 2019. Reported hazard: Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
What should I do if I have this product?
Voluntary: Firm initiated · Letter